Vote Scores
Filings read through

How funds voted at Marinus Pharmaceuticals, Inc.

Filers reporting
170, year to 30 June 2024
Latest meeting on file
Meetings on file
1

In the year to 30 June 2024, 170 filers on Form N-PX reported votes at Marinus Pharmaceuticals, Inc.. The votes fall in one meeting. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 357 marks to the ballot items, each with or against management. 79.3% of the marks are with management.

On say-on-pay, 36 of the 162 reporting filers that marked the item voted against management. This is 22.2% of the filers. Of the reported shares, 29.1% went against management. The median of the 3,781 companies on this site with a say-on-pay item is 7.5% of filers and 2.9% of reported shares.

At the meeting of 22 May 2024, 28 fund families have a say-on-pay position with management and 5 have a position against management.

By filers reporting in the year to 30 June 2024, Marinus Pharmaceuticals, Inc. was number 2,671 of 11,775 companies with a page and votes in that year. In all seasons on file, category SECTION 14A SAY-ON-PAY VOTES is 30.4% of the vote records at Marinus Pharmaceuticals, Inc.. At all companies on this site, it is 12.3%.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 22 May 2024

170 filers reported votes at this meeting in the year to 30 June 2024. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

  1. Item 1: Director elections

    3 nominees. 86.7% of the reported votes are for. 26 filers withheld from or voted against at least one nominee.

    319 vote records from 66 filers. 0 of the 64 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 26 fund families
    • For 26
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    235 vote records from 167 filers. 36 of the 162 filers that marked the item voted against management. 5 filers gave no management mark.

    • Positions of 33 fund families
    • For 28
    • Against 5
    • Against management 5
  3. Item 3: Audit-related items (auditor ratification)

    107 vote records from 66 filers. 0 of the 64 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 26 fund families
    • For 26
  4. Item 4: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    112 vote records from 69 filers. 38 of the 67 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 26 fund families
    • For 9
    • Against 17
    • Against management 17

Positions of the fund families at the meeting of 22 May 2024

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Marinus Pharmaceuticals, Inc., meeting of 22 May 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund familySay-on-pay
AllianceBernsteinFor
BlackRock and iSharesFor
BNY MellonFor
Brighthouse FundsFor
Charles SchwabFor
Columbia ThreadneedleFor
DWSFor
EquitableFor
FidelityFor
Franklin TempletonAgainst, against management
Global XAgainst, against management
Goldman SachsFor
Guggenheim and RydexFor
InvescoFor
J.P. MorganFor
Janus HendersonFor
John Hancock and ManulifeFor
Lincoln FinancialFor
Morgan Stanley, Eaton Vance and CalvertFor
NationwideFor
Neuberger BermanAgainst, against management
Northern Trust and FlexSharesFor
Nuveen and TIAAFor
Pacific Life fundsFor
PGIM and PrudentialAgainst, against management
PrincipalFor
ProShares and ProFundsFor
SEIAgainst, against management
State Street and SPDRFor
T. Rowe PriceFor
VanguardFor
Victory CapitalFor
VoyaFor

Every meeting on file

Meetings of Marinus Pharmaceuticals, Inc., from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 2024170422.2%

Say-on-pay, season by season

Say-on-pay at Marinus Pharmaceuticals, Inc.: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 202417022.2%29.1%
Marinus Pharmaceuticals, Inc. and the median of companies on this site, year to 30 June 2024
Say-on-payThis companyMedian of companies on this site
Filers against management22.2%7.5%
Reported shares against management29.1%2.9%

The median covers 3,781 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at Marinus Pharmaceuticals, Inc. by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
DIRECTOR ELECTIONS31941.3%
SECTION 14A SAY-ON-PAY VOTES23530.4%
AUDIT-RELATED10713.8%
COMPENSATION11214.5%

The record at the SEC

Each link loaded on .

Cite this page

Vote Scores. How funds voted at Marinus Pharmaceuticals, Inc.. https://votescores.com/company/marinus-pharmaceuticals-inc/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of Marinus Pharmaceuticals, Inc. are on file?
1 meeting is on file, on 22 May 2024. 1 meeting has 20 or more reporting filers and has its own page.
Did filers report proposals from security holders at Marinus Pharmaceuticals, Inc.?
Not enough filers reported a proposal from security holders for the site to show one in the year to 30 June 2024. The ballot shows the items that filers did report.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. Marinus Pharmaceuticals, Inc. reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Marinus Pharmaceuticals, Inc., grouped by company. The name is the most common spelling among filers. The filers wrote the filings. Filings read through .